ONCOLOGY: New Drug RAD001 Plus Letrozole In Neoadjuvant Therapy For Breast Cancer

Audio Journal of Oncology, December 15th, 2007 Reporting from: San Antonio Breast Cancer Symposium, 13-16 December, 2007 New Drug RAD001 Plus Letrozole In Neoadjuvant Therapy For Breast Cancer JOSE BASELGA, Vall d’Hebron Hospital, Barcelona REFERENCE: ABSTRACT 2066 RAD001, a drug targeted at the mTor pathway, has been combined with letrozole in a randomised phase II trial in breast cancer. The investigators saw more responses in the experimental arm, and so Derek Thorne got the details from Jose Baselga of Vall d’Hebron Hospital in Barcelona.